Baylor University Medical Center, Dallas, TX 75246, USA.
Crit Care Clin. 2012 Jul;28(3):389-98, vi. doi: 10.1016/j.ccc.2012.04.006. Epub 2012 May 9.
Coagulopathy, one of the cardinal features of advanced liver disease, is related to multiple factors including impaired synthetic function, thrombocytopenia, excessive fibrinolysis, platelet dysfunction, and disseminated intravascular coagulopathy. In the intensive care unit, management of coagulopathy may require treatment, particularly in the actively bleeding patient or in preparation for invasive procedures. This article reviews the background of coagulopathy in patients with end-stage liver disease and management options and comments on common clinical scenarios.
凝血功能障碍是晚期肝病的主要特征之一,与多种因素有关,包括合成功能障碍、血小板减少症、纤维蛋白溶解过度、血小板功能障碍和弥散性血管内凝血。在重症监护病房,凝血功能障碍的治疗可能是必要的,特别是在有活动性出血的患者或在准备侵入性操作时。本文综述了终末期肝病患者凝血功能障碍的背景和治疗选择,并对常见的临床情况进行了评论。